Skip to main content
. Author manuscript; available in PMC: 2010 May 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2009 Apr 21;18(5):1515–1523. doi: 10.1158/1055-9965.EPI-08-1119

Table 1.

Baseline characteristics of colorectal cancer cases, colorectal adenoma cases and controls, Washington County, MD, 1975 to 2006

Colorectal cancer (CRC)
Colorectal adenomas
cases
controls
cases
controls
Characteristic n % n % p-value n % n % p-value
Cohort participation1
 CLUE I only (1974) 354 57.9 354 57.9 0 0.0 0 0.0
 CLUE II only (1989) 139 22.7 139 22.7 123 100.0 123 100.0
 CLUE I and II 118 19.3 118 19.3 matched 0 0.0 0 0.0 matched
Age in years (mean +/-SD)1 56.2 +/− 12.4 56.2 +/− 12.3 matched 55.1 +/− 9.7 54.9 +/− 9.6 matched
Sex1
 male 269 44.0 269 44.0 61 49.6 61 49.6
 female 342 56.0 342 56.0 matched 62 50.4 62 50.4 matched
Race1
 White 600 98.2 600 98.2 123 100.0 123 100.0
 other 11 1.8 00 1.8 matched 0 0.0 0 0.0 matched
Smoking status
 current 158 21.7 154 21.1 21 17.1 15 12.2
 former 230 31.6 197 27.0 52 42.3 41 33.3
 never 341 46.8 378 51.9 0.18 50 40.7 67 54.5 0.08
Body mass index (kg/m2)3
 < 25 102 39.7 104 40.5 52 42.3 51 41.5
 25–30 103 40.1 110 42.8 49 39.8 54 43.9
 30+ 52 20.2 43 16.7 0.51 22 17.9 18 14.6 0.71
NSAID use at baseline2
 Yes 176 24.1 209 28.7 38 30.9 29 23.6
 No 553 75.9 520 71.3 0.05 85 69.1 94 76.4 0.18
Family history of CRC3
 no 124 78.0 150 86.7 86 71.7 98 83.8
 yes 35 22.0 23 13.3 0.04 34 28.33 19 16.2 0.03
Recent hormone use3,4
 none 178 87.7 185 89.4 49 81.7 42 67.7
 any 25 12.3 22 10.6 0.64 11 18.3 20 32.3 0.10
1

matching factors

2

non-steroidal anti-inflammatory drugs (NSAID) use within 48 hours prior to blood draw

3

data obtained from CLUE II participants only

4

data presented for females only